Friday 6 November 2026 Export IQV’s income statement to Excel — free account

IQVIA Holdings Inc.

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.

Revenue: +8.00%
EPS: +10.2%
Free cash flow: −21.3%
Total debt: +7.42%

Quarter to September 2026, against a year earlier

264.53 0.74 +0.28%

Follow IQV

Alert me

Market cap: $43.7B
P/E: 31.8×
Fwd P/E: 34.8×
Dividend yield: —
F-score: 4/9
Altman Z: 2.05
Beneish M: −2.59
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

IQVIA Holdings Inc. (IQV) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
Research & Development Solutions	8,896	54.54%
Technology And Analytics Solutions	6,626	40.63%
Contract Sales & Medical Solutions	788	4.83%
Gross margin		33.29%
Operating margin		13.38%
Pre-tax margin		9.75%

Revenue by segment $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Research & Development Solutions	8,896 54.54%	8,527 55.35%	8,395 56.03%	7,921 54.97%	7,556 54.46%	5,760 50.71%	5,788 52.20%	5,465 52.49%	5,105 52.62%	4,737 69.51%
Technology And Analytics Solutions	6,626 40.63%	6,160 39.99%	5,862 39.12%	5,746 39.88%	5,534 39.89%	4,858 42.77%	4,486 40.46%	4,137 39.73%	3,682 37.95%	1,148 16.85%
Contract Sales & Medical Solutions	788 4.83%	718 4.66%	727 4.85%	743 5.16%	784 5.65%	741 6.52%	814 7.34%	810 7.78%	915 9.43%	930 13.65%
Revenue	16,310	15,405	14,984	14,410	13,874	11,359	11,088	10,412	9,702	6,815

Revenue by region $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Americas	7,745 47.49%	7,356 47.75%	7,552 50.40%	7,048 48.91%	6,848 49.36%	5,419 47.71%	5,462 49.26%	4,998 48.00%	4,606 47.47%	3,254 47.75%
Europe and Africa	5,185 31.79%	4,920 31.94%	4,459 29.76%	4,366 30.30%	4,357 31.40%	3,695 32.53%	3,477 31.36%	3,448 33.12%	3,286 33.87%	2,219 32.56%
Asia-Pacific	3,380 20.72%	3,129 20.31%	2,973 19.84%	2,996 20.79%	2,669 19.24%	2,245 19.76%	2,149 19.38%	1,966 18.88%	1,810 18.66%	1,342 19.69%
Revenue	16,310	15,405	14,984	14,410	13,874	11,359	11,088	10,412	9,702	6,815

Operating figures as reported in each quarter’s results release or filing

Figure	Quarter	Latest	A year before	Change
Book-to-bill ratio	Q3 FY2026	1.2×	1.2×	+4.35%
R&DS contracted backlog	Q3 FY2026	$32.6B	$32.4B	+0.62%
R&D Solutions quarterly bookings	Q3 FY2026	$3.2B	$2.6B	+23.08%
Remaining performance obligations	Q3 FY2026	$34.2B	$34.4B	−0.58%
Trailing-twelve-month book-to-bill ratio	Q1 FY2026	1.1×	1.1×	−2.63%

	Q3 FY2026	Q2 FY2026	Q1 FY2026	Q4 FY2025	Q3 FY2025	Q2 FY2025	Q1 FY2025	Q4 FY2024	Q3 FY2024	Q2 FY2024	Q1 FY2024	Q4 FY2023	Q3 FY2023	Q2 FY2023	Q1 FY2023	Q4 FY2022	Q3 FY2022	Q2 FY2022	Q1 FY2022	Q4 FY2021	Q3 FY2021	Q2 FY2021	Q1 FY2021	Q4 FY2020	Q3 FY2020	Q2 FY2020	Q1 FY2020	Q4 FY2019	Q3 FY2019	Q2 FY2019	Q1 FY2019	Q4 FY2018	Q3 FY2018	Q2 FY2018	Q1 FY2018
Book-to-bill ratio	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
R&DS contracted backlog	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
R&D Solutions quarterly bookings	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Remaining performance obligations	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Trailing-twelve-month book-to-bill ratio	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.